Reed SD, Li Y, Turner NA, Pasquale DK, et al. Economic Outcomes of Dalbavancin versus Standard Therapy in Staphylococcus aureus Bacteremia in the DOTS Randomized Clinical Trial. Clin Infect Dis 2026 Sep 17:ciag567. doi: 10.1093.
PMID: 42752824